Becker's Healthcare August 8, 2024
Madeline Ashley

Walgreens shared in an Aug. 7 Securities and Exchange Commission filing that it could sell off its entire stake in primary care clinic chain VillageMD.

“The company is currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses and VillageMD’s substantial ongoing and expected future cash requirement,” the filing said. “These options could include a sale of all or part of the VillageMD businesses, possible restructuring options and other strategic opportunities.”

The filings come after Walgreens saw a $5.8 billion loss in the second quarter of 2024 due to an investment devaluation in VillageMD.

Walgreens shared plans in late June to cut back on “a significant portion” of its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Does PBM Market Share Vary by Payer Type?
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more

Share This Article